Published Date : 14 Feb 20 | Views: 131 | Industry : Life Science
COPD and Asthma Segment to Grab Significant Share of the Market
The global market for nebulizer is primarily segmented into two segments, i.e. product and application. The product segment is further segmented into Mesh Nebulizer, Pneumatic Nebulizer, Ultrasonic Nebulizer, and Others, while the application segment consists of Asthma, COPD, Cystic Fibrosis and Others. COPD and Asthma segments are expected to capture a remarkable share of the market due to the increasing prevalence of both the diseases.
Acute Growth in the Asthma Patients to Lead the nebulizer market in North America
According to the CDC National Health Report, COPD (Chronic Obstructive Pulmonary Disease) is the third major cause of death in the United States. North America has been dealing with the growing incidence of asthma and COPD which is fuelling the growth of the nebulizer market in the region. Asia Pacific region has also not lagged when it comes to a sudden increase in cases of COPD and asthma. Thus, a growing number of patients requiring nebulizers throughout the Asia Pacific region is propelling the growth of the market.
Omran Launches Travel-Friendly MicroAIR U100 Nebulizer
Some of the key players operating in the market are Allied Healthcare Products, 3A Health Care, GF, DeVilbiss Healthcare, PARI, PHILIPS, Omron, Rossmax International Ltd., and CareFusion. These top companies functional in the market are focusing on launching high-tech nebulizers. For instance, Omron has recently launched a new pocket-size MicroAIR U100 nebulizer, which patients can take along with them while traveling.
Growing Preference for Home Healthcare Devices to Surge the Growth of the Market
A sluggish lifestyle along with constant technological advancement particularly in the healthcare industry has compelled people to prefer at-home services, thus strengthening the requirement for home healthcare devices such as nebulizers. Growing respiratory diseases among the elderly population and precautionary measures implemented by the government have boosted the demand for nebulizers across the globe.
However, the availability of various alternatives including MDI (Metered Dose Inhaler) and oral medicines are expected to create a negative impact on the growth of the market.